CellMP
CellMP is a Menlo Park-based contract manufacturing organization providing technology transfer, process development, and clinical manufacturing services for cell therapy products, serving biotech and pharmaceutical companies developing cell therapies from research through early-stage clinical trials.
- Company typePrivate
- Founded2019
- HeadquartersMenlo Park, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What CellMP does
CellMP (legal entity: Cell Manufacturing and Production, LLC) is a Menlo Park, California-based contract manufacturing organization (CMO) specializing in cell therapy products. Founded in 2019, the company provides three integrated service lines: Technology Transfer (bridging research-stage projects into clinically compliant cell therapies), Process Development (encompassing characterization, scale-up, optimization, and validation of manufacturing activities), and Clinical Manufacturing (supporting pre-clinical IND-enabling studies and early-stage human trials). All operations are conducted from a single state-of-the-art facility at 3475 Edison Way, Suite T, Menlo Park, CA 94025. The company maintains a quality assurance program specifically designed to meet regulatory standards required for cell therapy product development.
The company's technology centers on bioprocess expertise rather than software platforms. Its proprietary service capabilities span the full pre-clinical to early-clinical manufacturing workflow for cell therapy developers, including assessment of stage-appropriate manufacturing needs, process gap-bridging, and characterization/validation activities. The offering is positioned as end-to-end support for biotech and pharmaceutical companies seeking to advance cell therapies from research laboratory through regulatory submission.
CellMP operates as a B2B professional services firm, generating revenue through project-based contracts with cell therapy developers. Pricing is not publicly disclosed and is determined through direct business development discussions based on client requirements, manufacturing scope, and regulatory compliance needs. The go-to-market motion relies on direct sales engagement, industry conferences, scientific publications, and direct outreach to biotech companies. The company currently operates domestically within the United States, serving the California biotech corridor, and has a headcount of 1-10 employees. No external funding rounds, acquisitions, or partnerships have been disclosed.
CellMP firmographics
Firmographics- Name
- CellMP
- Legal name
- Cell Manufacturing and Production, LLC
- Website
- https://cellmp.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- CellMP is a Menlo Park-based contract manufacturing organization providing technology transfer, process development, and clinical manufacturing services for cell therapy products, serving biotech and pharmaceutical companies developing cell therapies from research through early-stage clinical trials.
- Ownership category
- akta.pro rank
CellMP industry classification
Industry- Product category
- Cell Therapy Contract Manufacturing
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Cell Therapy CDMO (HLAGABAD)
- akta.pro secondary industries
- Cell Therapy CDMO (Autologous/Allogeneic Manufacturing) (HLAGAGAA), Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Cell Therapy Manufacturing Services (GMP, autologous/allogeneic) (HLAAAKAC), Cell Therapy Manufacturing Platforms & Automation (closed systems, bioreactors, fill-finish) (HLAAABAG)
Keywords
Where CellMP is headquartered
LocationHeadquarters
- HQ city
- Menlo Park
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
CellMP business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain
Revenue model
- Contract Manufacturing Services: CellMP provides contract manufacturing services for cell therapy products, supporting pre-clinical research, IND-enabling studies, and clinical manufacturing for early-stage human trials. Revenue is generated through project-based contracts with biotech and pharmaceutical companies requiring specialized cell therapy manufacturing capabilities.
- Technology Transfer Services: Fees for technology transfer services that help assess needs and bridge process gaps for companies moving products from research laboratory to clinic. These are consulting and technical proficiency services billed as part of project engagements.
- Process Development Services: Revenue from process development, characterization, scale-up, optimization, and validation services for cell therapy manufacturing. These specialized services are typically billed as project-based or contract engagements.
Go-to-market motion1 record
Distribution channels1 record
CellMP product offering
Product offeringCore offering
CellMP is a cell therapy contract manufacturing organization that provides Technology Transfer, Process Development, and Clinical Manufacturing services from its Menlo Park, California facility. The company specializes in process development, characterization, scale-up, optimization, and validation of manufacturing activities for cell therapy products. It supports clients across pre-clinical research, IND-enabling studies, and clinical manufacturing for early-stage human trials, with a quality assurance program designed for regulatory compliance.
Product overview
CellMP is a cell manufacturing and production company offering a unified service portfolio comprising three integrated offerings: Technology Transfer, Process Development, and Clinical Manufacturing. These services work together to guide clients from research laboratory through regulatory submission to early-stage clinical trials, with all operations conducted at their state-of-the-art facility in Menlo Park, CA.
Differentiator
Problem solved
Functional benefit
Products and services
- Technology Transfer Service that assesses stage-appropriate manufacturing needs for each client company and bridges process gaps to turn research-stage cell therapy projects into compliant products ready for clinical application.
- Process Development Comprehensive cell therapy manufacturing service encompassing process development, characterization, scale-up, optimization, and validation. Conducted at CellMP's Menlo Park facility and supported by a quality assurance program for pre-clinical research, IND-enabling studies, and clinical manufacturing.
- Clinical Manufacturing Manufacturing service conducted at CellMP's Menlo Park, CA facility to support pre-clinical research, IND-enabling studies, and clinical manufacturing for early-stage human trials in cell therapy products.
Companies that use CellMP
Customer profileSegments1 record
Ideal customer profiles1 record
CellMP technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
CellMP partnerships and signals
Strategic signalScale indicators1 record
Recent moves3 records
CellMP competitors and assessment
Company assessmentEmerging players
- Vineti: Vineti provides cell therapy orchestration and manufacturing execution software. While not a direct manufacturing competitor, it operates in the same cell therapy value chain (clinical manufacturing workflows) and competes indirectly for cell therapy sponsor budgets.
Direct peers
- AGC Biologics: AGC Biologics offers cell therapy and gene therapy CDMO services including process development and GMP manufacturing. It is comparable to CellMP because of its focus on cell therapy CDMO services for biotech developers across pre-clinical and clinical stages.
- RoslinCT: RoslinCT is a focused cell therapy CDMO offering process development, GMP manufacturing, and technology transfer for cell and gene therapies. It directly mirrors CellMP's end-to-end service model spanning tech transfer to clinical manufacturing.
- FUJIFILM Cellular Dynamics: FUJIFILM Cellular Dynamics provides iPSC-derived cell products and cell therapy manufacturing services. It is comparable to CellMP because it serves the cell therapy development market with process development and manufacturing capabilities at higher scale.
- KBI Biopharma: KBI Biopharma is a CDMO offering cell line development, process development, and clinical manufacturing services including for cell therapy. It is comparable to CellMP because it provides similar process development and clinical manufacturing services to biotech sponsors.
- WuXi Advanced Therapies Unit: WuXi AppTec's Advanced Therapies Unit provides cell therapy process development, viral vector manufacturing, and clinical manufacturing. It competes with CellMP for biotech clients needing IND-enabling and early-clinical cell therapy manufacturing support.
Broad incumbents
- Charles River Laboratories: Charles River Laboratories is a large CRO/CDMO with cell therapy manufacturing and testing capabilities through its Biologics Services. It overlaps with CellMP in serving cell therapy developers needing process development and manufacturing support, though across a much broader portfolio.
- Lonza (Cell & Gene Technologies): Lonza is one of the largest global CDMOs with a dedicated Cell & Gene Technologies business offering process development, GMP manufacturing, and fill-finish for cell therapies. It competes with CellMP for early-stage cell therapy manufacturing but at vastly larger scale and geographic reach.
- Catalent: Catalent is a major global CDMO with cell therapy development and clinical manufacturing capabilities. It is comparable to CellMP because it serves the same biotech client base needing process development and clinical-stage cell therapy manufacturing, though at significantly larger scale.
- Thermo Fisher Scientific (Patheon/Cell Therapy Services): Thermo Fisher provides cell therapy manufacturing services through Patheon and dedicated cell therapy offerings. It is comparable to CellMP because it serves the same biotech client base requiring clinical-stage cell therapy manufacturing and process development support.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
CellMP social profiles
Digital presenceCellMP financial estimates
Financial estimateRevenue estimate
Valuation estimate
CellMP leadership team
Management profileNumber of profiles
CellMP funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CellMP M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CellMP
What does CellMP do?
CellMP is a cell therapy contract manufacturing organization that provides Technology Transfer, Process Development, and Clinical Manufacturing services from its Menlo Park, California facility. The company specializes in process development, characterization, scale-up, optimization, and validation of manufacturing activities for cell therapy products. It supports clients across pre-clinical research, IND-enabling studies, and clinical manufacturing for early-stage human trials, with a quality assurance program designed for regulatory compliance.
Is CellMP a public or private company?
CellMP is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was CellMP founded?
CellMP was founded in 2019. It employs 1 to 10 people.
Where is CellMP based?
CellMP is headquartered in Menlo Park, United States, in the North America region.
How does CellMP make money?
Three revenue lines are on record. Contract Manufacturing Services are the primary driver. The others are technology Transfer Services and process Development Services.
Who are CellMP's main competitors?
Vineti is listed as an emerging player. Direct peers are AGC Biologics, RoslinCT, FUJIFILM Cellular Dynamics, KBI Biopharma and WuXi Advanced Therapies Unit. Broad incumbents are Charles River Laboratories, Lonza (Cell & Gene Technologies), Catalent and Thermo Fisher Scientific (Patheon/Cell Therapy Services).
Does CellMP have an API?
No public API is recorded for CellMP.
What industry is CellMP in?
CellMP's product category is Cell Therapy Contract Manufacturing. Its primary akta.pro industry code is HLAGABAD, Cell Therapy CDMO, with a secondary code of HLAGAGAA, Cell Therapy CDMO (Autologous/Allogeneic Manufacturing). Its NAICS code is 54171 and its SIC code is 8731.